Luzalba Sanoja-Flores

9PUBLICATIONS
44CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 31, 2026
BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

Jose Antonio Bejarano-Garcia, Melanie Nufer, Mª José Palacios-Barea

|Dec 10, 2023
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study.

Oihane Pérez-Escurza, Juan Flores-Montero, Jón Þórir Óskarsson

|Mar 11, 2023
Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil.

Anna Beatriz Dos Santos Salgado, Roberto Jose Pessoa Magalhães, Robéria M Pontes

|Jun 06, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.

Juan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig

|Oct 13, 2021
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.

Noemí Puig, Juan Flores-Montero, Leire Burgos

|Apr 30, 2021
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.

Robéria Mendonça de Pontes, Juan Flores-Montero, Luzalba Sanoja-Flores

Pageof 2

Frequent Collaborators

8 joint publications

Juan Flores-Montero

7 joint publications

Alberto Orfao

4 joint publications

Maria-Victoria Mateos

3 joint publications

Bruno Paiva